American Herbal Pharmacopoeia monograph lays scientific foundation for quality assurance and expanded research
The American Herbal Pharmacopoeia (AHP), in a historic move, on Wednesday released the first installation of a two-part Cannabis monograph that classifies cannabis (marijuana) as a botanical medicine, alongside many other widely accepted complementary and alternative medicines.
Written and reviewed by the world's leading experts, the cannabis monograph brings together an authoritative compendium of scientific data, including long-awaited standards for the plant's identity, purity, quality, and botanical properties. The monograph provides a foundation for health care professionals to integrate cannabis therapy into their practices on the basis of a full scientific understanding of the plant, its constituent components, and its biologic effects.
"The inclusion of cannabis in the American Herbal Pharmacopoeia returns the plant to its place alongside as a proven botanical medicine, which has been used for centuries by countries and cultures around the world," said Steph Sherer, executive director of Americans for Safe Access (ASA), which helped support the development of the cannabis monograph.
"Health care professionals, researchers and regulators now have the tools to develop effective public health programs for medical marijuana and to further explore its therapeutic benefits," Sherer said.